Form 4 for MIAX MIAMI INTERNATIONAL HOLDINGS, INC.
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001628280-25-040789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-19 | 2025-08-15 | MIAX | Jayabalan Harish | EVP, CRO, CISO | C - Cnv Deriv | — | +43.9K | 50.4K | +682% | — |
| DM | 2025-08-19 | 2025-08-15 | MIAX | Jayabalan Harish | EVP, CRO, CISO | C - Cnv Deriv | $0.00 | -43.9K | 0 | -100% | $0 |
| DM | 2025-08-19 | 2025-08-15 | MIAX | Jayabalan Harish | EVP, CRO, CISO | M - OptEx | $0.00 | 0 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | C | A | 43,442 | — | 50,385 | D | — | — | (F2) Represents 43,442 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date. 4,500 of those shares are held jointly with his spouse with right of survivorship. |
| 2 | Common | Common Stock | 2025-08-15 | C | A | 500 | — | 50,385 | D | — | — | (F1) Represents 500 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date. |
| 3 | Derivative | Series B Preferred Stock | 2025-08-15 | C | D | 500 | $0.00 | 0 | D | — · — to — | 500 Common Stock | (F1) Represents 500 shares of Series B Preferred Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's initial public offering ("IPO") and which have no expiration date. |
| 4 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 8,621 | $0.00 | 8,621 | D | $25.78 · — to 2032-03-09 | 8,621 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 5 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 21,999 | $0.00 | 0 | D | $12.00 · — to 2025-09-17 | 21,999 Series B Preferred Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 6 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 21,999 | $0.00 | 21,999 | D | $12.00 · — to 2025-09-17 | 21,999 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 7 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 16,666 | $0.00 | 0 | D | $12.00 · — to 2027-10-12 | 16,666 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 8 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 16,666 | $0.00 | 16,666 | D | $12.00 · — to 2027-10-12 | 16,666 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 9 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 8,333 | $0.00 | 0 | D | $12.00 · — to 2028-05-17 | 8,333 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 10 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 8,333 | $0.00 | 8,333 | D | $12.00 · — to 2028-05-17 | 8,333 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 11 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 8,333 | $0.00 | 0 | D | $12.00 · — to 2029-07-31 | 8,333 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 12 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 8,333 | $0.00 | 8,333 | D | $12.00 · — to 2029-07-31 | 8,333 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 13 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 6,570 | $0.00 | 0 | D | $15.22 · — to 2030-11-30 | 6,570 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 14 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 6,570 | $0.00 | 6,570 | D | $15.22 · — to 2030-11-30 | 6,570 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 15 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 6,195 | $0.00 | 0 | D | $16.14 · — to 2031-09-09 | 6,195 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 16 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 6,195 | $0.00 | 6,195 | D | $16.14 · — to 2031-09-09 | 6,195 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 17 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | D | 3,878 | $0.00 | 0 | D | $25.78 · — to 2032-03-09 | 3,878 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 18 | Derivative | Incentive Stock Option (Right to Buy) | 2025-08-15 | M | A | 3,878 | $0.00 | 3,878 | D | $25.78 · — to 2031-03-09 | 3,878 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 19 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 3,001 | $0.00 | 0 | D | $12.00 · — to 2025-09-17 | 3,001 Series B Preferred Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 20 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 3,001 | $0.00 | 3,001 | D | $12.00 · — to 2025-09-17 | 3,001 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 21 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 20,834 | $0.00 | 0 | D | $12.00 · — to 2027-10-12 | 20,834 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 22 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 20,834 | $0.00 | 20,834 | D | $12.00 · — to 2027-10-12 | 20,834 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 23 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 16,667 | $0.00 | 0 | D | $12.00 · — to 2028-05-17 | 16,667 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 24 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 16,667 | $0.00 | 16,667 | D | $12.00 · — to 2028-05-17 | 16,667 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 25 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 16,667 | $0.00 | 0 | D | $12.00 · — to 2029-07-31 | 16,667 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 26 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 16,667 | $0.00 | 16,667 | D | $12.00 · — to 2029-07-31 | 16,667 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 27 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 23,430 | $0.00 | 0 | D | $15.22 · — to 2030-11-30 | 23,430 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 28 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 23,430 | $0.00 | 23,430 | D | $15.22 · — to 2030-11-30 | 23,430 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 29 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 26,304 | $0.00 | 0 | D | $16.14 · — to 2031-09-09 | 26,304 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 30 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | A | 26,304 | $0.00 | 26,304 | D | $16.14 · — to 2031-09-09 | 26,304 Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 31 | Derivative | Nonqualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 8,621 | $0.00 | 0 | D | $25.78 · — to 2032-03-09 | 8,621 Nonvoting Common Stock | (F3) The options were granted initially as the right to buy Nonvoting Common Stock or Series B Preferred Stock, as applicable. On the closing date of the IPO, these converted to the right to buy Common Stock instead of Nonvoting Common Stock or Series B Preferred Stock, as applicable, for the same price and under the same conditions. (F4) The options are fully vested. |
| 32 | Derivative | Nonvoting Common Stock | 2025-08-15 | C | D | 43,442 | $0.00 | 0 | D | — · — to — | 43,442 Common Stock | (F2) Represents 43,442 shares of Nonvoting Common Stock that have been converted into shares of Common Stock on a one-for-one basis upon the closing of the Company's IPO and which have no expiration date. 4,500 of those shares are held jointly with his spouse with right of survivorship. |